Avenda Health
-
Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance
Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.
-
Avenda Health scores $10M to personalize prostate cancer care
Avenda Health, an AI company focused on personalized prostate cancer care, recently closed a $10 million Series B funding round. The company’s platform seeks to personalize treatment to the patient and their specific case to preserve quality of life and prevent cancer recurrence.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.